When cardiopulmonary support or cardiac surgery are necessary, our advanced cardiovascular technologies can significantly improve patient outcomes. Our devices and systems are used in more than half of all open-heart surgeries worldwide. Our heart-lung machines have led the market for 40+ years, and we’re recognized as the number one cardiopulmonary bypass company worldwide. LivaNova is committed to continuous innovation with global R&D centers developing better technologies for heart conditions.
Understanding a diagnosis and learning about a disease can help you evaluate treatment options.
Access information on our products and related resources. Learn about our professional education opportunities.